Daily BriefsIndia

India: INR 10Y, Indraprastha Gas, ITC Ltd, Kajaria Ceramics, Manappuram Finance, Multi Commodity Exchange India, Pi Industries, Star Cement Ltd and more

In today’s briefing:

  • Yields in Asia Are Far from the Peak – Part II
  • Indraprastha Gas – PAT Beat of 26.9% on Lower Gas Cost
  • ITC: Healthy OverallPerformance
  • ITC Ltd – Robust Operating Performance- Dividend Yield Improves Further
  • HSIE Results Daily: Kajaria Ceramics
  • Manappuram Finance – Customer Acquisition Weak Amid High Competition, Weak Demand
  • 4QFY22 Results Update – MCX
  • PI Industries – Domestic Revenue Growth Outpaces Exports
  • Star Cement: Encouraging Volume Growth; Better Cost Management
  • Star Cement Ltd – Volume Growth Finally Kicks In, Driving Earnings Beat

Yields in Asia Are Far from the Peak – Part II

By Gautam Jain, PhD, CFA

  • Even as the US 10y yield has come off the peak, rates in emerging markets – including in Asia – have been selling off as they remain under pressure.
  • Rates in Asia are vulnerable as they are expensive vis-à-vis the rest of EM, rising inflation should result in further rate hikes in the region, and debt profiles have deteriorated.
  • I thus expect rates in Asia to underperform and prefer selling bonds in the region paired with long bond positions in countries in other regions.

Indraprastha Gas – PAT Beat of 26.9% on Lower Gas Cost

By Nirmal Bang

  • Revenue grew by 55.2% YoY to Rs24.06bn vs NBIE estimate of Rs24.56bn, a 2.1% miss on our estimate and 0.38% miss vs street estimate.
  • Gross margin came in at 36.9% vs our estimate of 32% as COGS was 9.1% below our estimate while revenue miss was 2.1%.
  • PBT was up 33.2% vs NBIE estimate at Rs4.95bn; Share of JV/Associates was a 11.8% beat at Rs723mn.

Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.


ITC: Healthy OverallPerformance

By Axis Direct

  • ITC reported a healthy set of numbers in Q4FY22with Revenue of Rs 15,331Cr (our estimate – Rs16,205Cr), down 2.2%QoQ but up ~16.5% YoY, led by a strong 8% volume growth in Cigarettes (in line with our estimates).
  • Gross Margins at 52.5% was 132bps lower YoY on account of unprecedented RM inflation
  • Benign taxation, inexpensive valuations (20x FY24E EPS), 5% dividend yield makes us BUYers of the stock. Our TP is revised to Rs 295 (earlier Rs 280).

Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.


ITC Ltd – Robust Operating Performance- Dividend Yield Improves Further

By Nirmal Bang

  • 4QFY22 headline performance: ITC’s 4QFY22 standalone topline (adjusted for excise duty) was up 16.8% YoY at Rs155bn vs our est. of 21.9% YoY growth to Rs162bn.
  • 4QFY22 segmental performance: Cigarette revenue grew by 10% YoY to Rs64.4bn (vs our est. of Rs65.3bn), up ~12% on a two-year CAGR basis.
  • FY22 performance: Standalone Revenue, EBITDA and APAT grew by 23.9%, 22% and 15.5%, respectively.

Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.


HSIE Results Daily: Kajaria Ceramics

By HDFC Securities

  • Q4FY22 performance: Kajaria posted lower-than-estimated margin (~200bps miss) in Q4FY22, as margin compressed QoQ on rising gas prices (crude linked).
  • Tiles sales volumes/revenue rose 2/16% YoY (2-year CAGR 19/29%). Outsourced volume continues to lead growth (+12% YoY, 2-year CAGR 39%).
  • Outlook: For FY23, KJC targets volume/revenue growth of ~15-20%/20-25%.

Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.


Manappuram Finance – Customer Acquisition Weak Amid High Competition, Weak Demand

By Nirmal Bang

  • Yields remain under pressure; likely to recover: Net yield in 4QFY22 declined to 18.8% from 20.3% in 3QFY22 and 25.3% in 2QFY22 amid high competition from other lenders.
  • Gold loan AUM down QoQ; uptick in NPA not worrisome: Total gold loans AUM declined 1.4% QoQ while gold holdings/collateral declined by 2.9% QoQ.
  • MFI growth revive in FY23: In 4QFY22, the company scaled back growth in the MFI business as it prioritized improvement in asset quality and collections.

Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.


4QFY22 Results Update – MCX

By Motilal Oswal

  • Strong operational performance, an exceptional item impacts PAT –Overall futures ADT improved by 4% QoQ and options ADT jumped by 70%, which resulted in a 19% rise in revenue ahead of our estimate.
  • Healthy volume growth driven by Crude Oil – Total volumes grew 29% YoY and 21% QoQ to INR26t in 4QFY22.
  • Key takeaways from the management commentary – MCX is awaiting approval from the regulators (Sebi and CERC) to launch Electricity derivatives.

Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.


PI Industries – Domestic Revenue Growth Outpaces Exports

By Nirmal Bang

  • Key positives: (i) PI added 8 new customers in FY22 (ii) New thrust on non-agrochem CSM – 35% of its 36 enquiries (iii) PI’s goal is to develop high-value CSM services in Agrochem/Pharma/Specialty Chemicals, based on cost leadership and sustainable manufacturing through differentiated technology/synthesis.
  • We see a bull case/bear case valuation of Rs3,318/Rs2,943 based on 100%/nil impact of the DCF value of a potential M&A deal for a Pharma asset.
  • 4QFY22 results are lower than our estimates. Revenue at Rs13.95bn was a miss of 1.1% vs NBIE estimate, but a beat of 2% vs street estimate.

Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.


Star Cement: Encouraging Volume Growth; Better Cost Management

By Axis Direct

  • Star Cement (SCL) reported robust revenue/volume growth of 27%/24%YoY in Q4FY22, driven by higher demand in its operating region. However, lower realization impacted the company’s margins
  • The stock is currently trading at 8x FY23E and 7x FY24E EV/EBITDA
  • We retain our BUY rating on the stock and value the company at 8x FY24E EV/EBITDA to arrive at a target price of Rs 105/share, implying an upside of 14% from the CMP.

Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.


Star Cement Ltd – Volume Growth Finally Kicks In, Driving Earnings Beat

By Nirmal Bang

  • 4QFY22 performance: In 4QFY22, the company reported volume growth of 27% YoY (up by 33% QoQ) at 1.15mn mt, which was 20.1% above our estimate.
  • Higher domestic coal sourcing will keep costs lower for STRCEM: The company has used low-cost coal inventory, which was available from CIL (~200k mt). It has a long-term FSA with CIL for 150k mt of coal on an annual basis at a fixed price, which will mitigate the risk of price hikes in the future.
  • Capex and expansion plan: A 3mn mt clinker unit in Meghalaya and a 2mn mt grinding unit in Guwahati are expected to be commissioned by the end of CY23.

Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.


Before it’s here, it’s on Smartkarma